Matthew R. Nelson BS, PhD

Matt Nelson is the Head of Genetics at GSK, working in Philadelphia, PA. He leads a group of scientists to bring genetic evidence into both drug discovery and drug development decisions. Research activities of personal interest include investigating the role of growing body genome-wide association studies to inform drug target selection and validation, improving pharmacogenetics experiment design and developing methods and strategies for drawing inferences from both small- and large-scale genetic association studies. Matt graduated from the University of Michigan in statistics and human genetics. He has previously worked with Sequenom and Esperion Therapeutics